LOTRONEX
These highlights do not include all the information needed to use LOTRONEX safely and effectively. See full prescribing information for LOTRONEX. LOTRONEX (alosetron hydrochloride) Tablets Initial U.S. Approval: 2000
35cbb9d5-639b-207a-e054-00144ff88e88
HUMAN PRESCRIPTION DRUG LABEL
May 3, 2019
Sebela Pharmaceuticals Inc.
DUNS: 079104574
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
alosetron hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
alosetron hydrochloride
Product Details
FDA regulatory identification and product classification information